arrow
Back
N

Novartis Pharma Ag, Basel, Switzerland

Scholars38
Papers15
Citations0
Related Papers (14)
Publication Date
Long-Term Efficacy and Safety of Ligelizumab as Re-Treatment in Patients With Chronic Spontaneous Urticaria
err2025-12-08
err0
errOAAI
errAna M. Gimenez-Arnau; Marcus Maurer; Adam Reich; Chia-Yu Chu; Diana Deleanu; Gordon Sussman; Jorge Sanchez; Knut Brockow; Koremasa Hayama; Michihiro Hide; Mohamed Denguezli; Raisa Meshkova; Roberta F. J. Criado; Sarbjit Saini; Solange Valle; Eva Hua; Pengpeng Wang; Alis Burciu; Isabelle Indermuehle; Vineeth Varanasi; Yolandi Joubert; Thomas Severin; Manmath Patekar
errShare
errSave
Combining Machine-Learning Assessment of Multiple MRI Pathologies and Clinical Phenotypes for Predicting Joint Replacement in Knee Osteoarthritis: Data From the Osteoarthritis Initiative
err2025-12-05
err0
PREAI
errG. D’Assignies; D. Demanse; F. Saxer; D. Laurent; P. Zille; T. Vesoul; P. Cordelle; G. Herpe; P.G. Conaghan; M. Schieker
errShare
errSave
Impact of Erenumab on Comorbid Depression, Anxiety, and Sleep Quality in Migraine: A Registry for Migraine (REFORM) Study
err2025-11-07
err0
errOAAI
errBianca Raffaelli; Janu Thuraiaiyah; Rune Häckert Christensen; Haidar M. Al-Khazali; Håkan Ashina; Josefin Snellman; Tina Maio-Twofoot; Messoud Ashina
errShare
errSave
Reply to the letter regarding the article ‘Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial’
err2025-10-14
err0
PREAI
errLuis Eduardo Echeverria; Caroline Demacq; Claudio Gimpelewicz; John J.V. McMurray; Renato Delascio Lopes;  on behalf of the PARACHUTE-HF Investigators
errShare
errSave
Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial
err2025-09-08
err0
PREAI
errLuis Eduardo Echeverria; Edimar Bocchi; Caroline Demacq; Pedro Gabriel Melo de Barros e Silva; Lu-May Chiang; Sarfaraz Sayyed; Lucas Petri Damiani; Lilian Mazza Barbosa; Remo Holanda de Mendonça Furtado; Carlos A. Morillo; Ruben Kevorkian; Felix Ramires; Maria Cecilia Bahit; Adolfo Chavez-Mendoza; José Antonio Magaña-Serrano; Justo Carbajales; Wilson Oliveira Junior; Israel Molina; Aguinaldo F. Freitas Junior; Maria da Consolaçao Moreira; Adegil Henrique Silva; Telemaco Silva Junior; Wladimir Saporito; José Francisco Kerr Saraiva; Claudio Gimpelewicz; John J.V. McMurray; Renato Delascio Lopes;  on behalf of the PARACHUTE-HF Investigators
errShare
errSave
Model-Informed Drug Development for Ligelizumab in Patients With Chronic Spontaneous Urticaria
err2025-08-23
err0
errOAAI
errAndrzej Bienczak; Aurelie Gautier; Eva Hua; Yan Ji; Emil Scosyrev; Serge Smeets; Thomas Severin; Anton Drollmann; Manmath Patekar; Marina Savelieva
errShare
errSave
Secukinumab in the Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Pooled Pharmacokinetics and Safety Results From the SUNSHINE and SUNRISE Phase 3 Studies
err2025-08-21
err0
errOAAI
errAfsaneh Alavi; Ziad Reguiai; Gregor B. E. Jemec; Alice B. Gottlieb; Magdalena B. Wozniak; Lorenz Uhlmann; Heng Fan; Angela Llobet Martinez; Gerard Bruin; Nicolas Thomas; Ivette Alarcon; Bruno Bieth; Shoba Ravichandran; Alexa B. Kimball
errShare
errSave
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response
err2025-08-03
err0
errOAAI
errMaximilian Einsiedler; Aleksandra Maleska Maceski; Sofia Sandgren; Johanna Oechtering; Sabine Schaedelin; Lisa Hofer; Amar Zadic; Juan Francisco Vilchez Gomez; Lester Melie-Garcia; Alessandro Cagol; Riccardo Galbusera; Sebastian Finkener; Patrice Lalive; Marjolaine Uginet; Stefanie Müller; Caroline Pot; Amandine Mathias; Renaud Du Pasquier; Robert Hoepner; Andrew Chan; Giulio Disanto; Chiara Zecca; Marcus D’Souza; Lars G. Hemkens; Tobias Derfuss; Özgür Yaldizli; Patrick Roth; Claudio Gobbi; David Brassat; Björn Tackenberg; Henrik Zetterberg; Tjalf Ziemssen; Heinz Wiendl; Klaus Berger; Marco Hermesdorf; Fredrik Piehl; Ludwig Kappos; Cristina Granziera; Ahmed Abdelhak; David Leppert; Eline A. J. Willemse; Pascal Benkert; Jens Kuhle; Swiss Multiple Sclerosis Cohort Study (SMSC)
errShare
errSave
The Basel Modeling and Simulation Seminar: 20 Editions of Fostering Local Exchange in Pharmacometrics
err2025-07-31
err0
errOAAI
errTamara van Donge; João A. Abrantes; Kai Grosch; Gilbert Koch; Meemansa Sood; Britta Steffens; Andreas Krause
errShare
errSave
Normalization of Cerebral Hemodynamics After Gene Therapy in Adults With Sickle Cell Disease
err2025-06-27
err0
PREAI
errAkshay Sharma; Jane S. Hankins; Jaap-Jan Boelens; Maria Cancio; Radhika Peddinti; Lawrence Rispoli; Sarah Sloan; Sarah DiDominick Costa; Sharon Peled; Andrea Wiethoff; Ranganatha Sitaram; James L. LaBelle
errShare
errSave
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab
err2025-06-06
err0
errOAAI
errJan Brandt-Jürgens; Martin Rudwaleit; Frank Behrens; Christopher Ritchlin; Daniel Peterlik; Erhard Quebe-Fehling; Atul Deodhar
errShare
errSave
Prevalence, treatment and burden of chronic spontaneous urticaria in five European countries
err2025-06-05
err0
errOAAI
errMaria-Magdalena Balp; Kathryn Krupsky; Shaloo Gupta; Clementine Lienhard; Ravneet K. Kohli; Dhaval Patil; Florence Tétart; John Reed; Tariq El-Shanawany
errShare
errSave
Model-Informed Drug Development-Based Bridging from Subcutaneous to Intravenous Secukinumab Dosing: Approval in Psoriatic Arthritis and Axial Spondyloarthritis
err2025-06-02
err0
errOAAI
errThomas Dumortier; Guillermo Valenzuela; Melvin Churchill; Jelena Mijatovic; Gerard Bruin; Luminita Pricop; Hanno Richards; Didier Renard; Atul Singhal; Anshu Marathe
errShare
errSave
Association between NT-proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA-HF and PARADIGM-HF
err2025-05-12
err0
errOAAI
errRobert Shaddy; Jianjian Gong; Tania Garito; Susan Solar-Yohay; Sijia Zhang; Margaret F. Prescott; Damien Bonnet; Paul F. Kantor; Michael Burch
errShare
errSave